Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05343533 · ClinicalTrials.gov registry record · NA

Probiotic Administration on Mood

A NA study, sponsored by Lindenwood University.

Completed
Registry status
NA
Development phase
70
Enrollment target

NCT05343533: Completed NA study, sponsored by Lindenwood University.

NCT05343533 is a NA study that has completed, run by Lindenwood University. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05343533, a NA study, has completed, sponsored by Lindenwood University.

COMPLETED
Registry status
NA
Development phase
70 participants
Enrollment target

Study Summary

Researchers are looking to examine the impact of probiotic administration on symptoms commonly associated with depression, anxiety, stress, sleep quality, and associated emotional responses in healthy men and women.

Primary Outcome

The Beck Depression Inventory (BDI) is a 21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression. Total Score Levels of Depression 0-10 = These ups and downs are considered normal 11-16 = Mild mood disturbance 17-20 = Borderline clinical depression 21-30 = Moderate depression 31-40 = Severe depression over 40 = Extreme depression

Interventions

  • DIETARY_SUPPLEMENT Probiotic

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2019-07-17
Est. Completion 2022-01-01
Phase NA
Lindenwood University

29 total trials

What the finished NCT05343533 record still lists

NCT05343533 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Probiotic is the first listed.

NCT05343533 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05343533 about?

NCT05343533 is a clinical study titled "Probiotic Administration on Mood". Researchers are looking to examine the impact of probiotic administration on symptoms commonly associated with depression, anxiety, stress, sleep quality, and associated emotional responses in healthy men and women.

What is the current status of trial NCT05343533?

This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2019-07-17. Estimated completion is 2022-01-01.

What interventions are being tested in trial NCT05343533?

The interventions under investigation include: Probiotic (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05343533?

This trial is sponsored by Lindenwood University, which has 29 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05343533's enrollment target sits among peer trials

70 1103rd of 2000 higher than 868 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05343533, the US trial registry maintained by the National Library of Medicine. NCT05343533 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.